More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Cynata Enters Agreement with apceth GmbH & Co KG

May 8, 2016 at 11:51 PM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · May 8, 2016 at 11:51 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/cynata-enters-agreement-with-apceth-gmbh-and-co-kg

Cynata Therapeutics Limited on 6ix

Earlier from Cynata Therapeutics

  • CYP Manufactures CT Product-Files Further Patent ApplicationMay 5, 2016
  • Decision to Grant Patent for Cymerus MSC Technology in JapanMay 2, 2016
  • Cynata & Regience Extend Entitlement PeriodApr 29, 2016
  • Compelling Results from Pre-Clinical Stem Cell Study in GvHDApr 6, 2016
  • Cynata Announces Landmark Licensing DealMar 30, 2016

Later from Cynata Therapeutics

  • Cynata Prepares for Phase 1 Clinical TrialJun 20, 2016
  • Cynata Receives Investment Offer from RegienceJun 30, 2016
  • Cynata Files Application to Commence Phase 1 Clinical TrialJul 31, 2016
  • CYP & FUJIFILM Sign Non-Binding Terms SheetSep 4, 2016
  • CYP Determines not to proceed with Regience Investment OfferSep 5, 2016
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer